- 1、本文档共6页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
2014年晚期非小细胞肺癌内科治疗进展
军 杂 201511401
10
2014
(
)(IASLC)Translational Lung
Cancer ResearchJournal of Thoracic Disease JTO
Military Medical Research
120SCI 72 6
4 333334
2
[]
2014 (ASCO)(ESMO)
(TKI)
2014
[]
[]R734.205.3 []A []0577-7402(2015)01-0010-06
[DOI]10.11855/j.issn.0577-7402.2015.01.03
Medical treatment of advanced non-small cell lung cancer: progress in 2014
SONG Yong, YANG Wen
Department of Respiratory and Critical Care Medicine, Nanjing General Hospital of Nanjing Command, Jinlin Hospital of Nanjing
University, Nanjing 210002, China
[Abstract]Non-small cell lung cancer is the most common pathological type of lung cancer. Along with the rising incidence
in recent years, lung cancer has been the leading cause of death due to malignancies both in our country and worldwide. Due
to simplistic therapeutic approach for lung cancer decades ago, those patients suffering from advanced lung cancer had short
lifetime, and it was difficult to ensure their life quality. In recent years, many molecular targeted drugs, suc
文档评论(0)